Transforming drug development

– by harnessing the power of applied genomics.

Our company

We apply bioinformatic approaches and AI to eliminate major risks associated with traditional drug development, as well as sharply reducing the enormous cost and time to bring effective treatments to millions of patients.

- We collaborate closely with The Center for Applied Genomics (CAG) at the Children’s Hospital of Philadelphia (CHOP) to develop ground-breaking new medical treatments

- We leverage over 20 years of genomics research, redefining and de-risking drug development

We use genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments.

Our unique approach to drug development is augmented by:

  • Nationwide genealogy database, comprising of all Icelanders from settlement.​
  • Biobank licensed by the Icelandic Ministry of Health.
  • Partnership with national hospitals, granting fully encrypted access to national Electronic Health Records (EHR) database.

Our R&D operations are run by a team of international experts in genetics, genomics, immunology, bioinformatics, and drug development.

- Our clinically-certified genotyping and sequencing facility is onstream in Iceland.

- We partner with leading international experts, key opinion leaders (KOLs), research organisations and universities, as well as Iceland’s National Hospital in Akureyri and Reykjavik, to advance our drug portfolio into the clinic ahead of strategic out-licensing.

Our winning formula

- is accelerating treatments for millions of patients

Pipeline

Indication
Pre clinical
Phase 1
Phase 2
Phase 3
Familial dementia and Alzheimer’s disease
Inflammatory skin diseases, such as acne vulgaris and atopic dermatitis
AT-003
Autoimmune diseases (MS, RA, SLE) and Parkinson’s
AT-002
Uveitis and rare auto- inflammatory diseases
AT-005
Severe asthma and rhinovirus type C infections

We are inspired by one of the leading minds in applied genomics

Leadership team

Founder & Chief Medical Advisor

Dr. Hakon Hakonarson

MD, PhD

Founder & Director of the
Center for Applied Genomics (CAG)

  • Founded by Dr. Hakonarson, who launced CAG in 2006 and established it as the largest pediatric biobank and genomic database in the world.
  • Dr. Hakonarson has published a vast amount of high-impact papers in prestigious scientific journals.
  • Time Magazine listed Dr. Hakonarson autism gene discovery project, reported in Nature in 2009, among the top ten medical breakthroughs that year.
  • Dr. Hakonarson Nat Med paper on a novel precision based therapy in lymphatic disorders was awarded among the top 10 clinical/translation papers in 2020 by the Clinical Research Forum.
  • Dr. Hakonarson was recently ranked among “the world's most influential scientific minds” by Thomson Reuters, with over 1000 publications and h-index of 171.
  • Before founding CAG, Dr. Hakonarson held various leadership roles with deCODE genetics, which was acquired AMGEN in 2012 in a deal valued at $450 million.

Phillip R. Harper
Chairman of the Board

Ívar Hákonarson
Co-founder & CEO

Lisa DeMarco
Chief Business Officer

Dr. Charlly Kao
Co-Founder & Chief Scientific Officer

Ásbjörn Kristbjörnsson
Chief Information Officer

Gulli Arnason
Chief Strategy Officer

Hugrún Lísa Heimisdóttir
Director of Grants & Contracts

Dr. Elizabeth Bhoj
Director of Clinical Operations

Dr. Ásbjörg Ósk Snorradóttir
Director of Clinical Development

AT in the news

EIC accelerator logo, 12 golden stars in a circle on a blue background

29.12.2022

Arctic Therapeutics awarded a highly prestigious multi-million grant from the EIC Accelerator

A D Scientific index logo

17.11.2022

Arctic Therapeutics’ founder and CMO, Hákon Hákonarson, ranked among the top 2% of scientists in the world

front page of the life science review magazine featuring Ívar Hákonarsson co founder of arctic therapeutics

24.10.2022

Arctic Therapeutics International Curing the incurable with precision medicine

usa today news logo

16.01.2022

Beyond Aduhelm: Why experts have never felt more optimistic about Alzheimer's treatments

EIC accelerator logo, 12 golden stars in a circle on a blue background

29.12.2022

Arctic Therapeutics awarded a highly prestigious multi-million grant from the EIC Accelerator

A D Scientific index logo

17.11.2022

Arctic Therapeutics’ founder and CMO, Hákon Hákonarson, ranked among the top 2% of scientists in the world

front page of the life science review magazine featuring Ívar Hákonarsson co founder of arctic therapeutics

24.10.2022

Arctic Therapeutics International Curing the incurable with precision medicine

usa today news logo

16.01.2022

Beyond Aduhelm: Why experts have never felt more optimistic about Alzheimer's treatments